ZYME Zymeworks Inc. - Common Stock
$29,59
Cena · Sie 25, 2026
Dane fundamentalne na dzień Sie 6, 2026
Zakres 52 tyg.
$14–$30
98% of range
Ocena Analityków
BUY
18 analysts
Cena Docelowa
$40
+36% upside
P/E (TTM)
-27.4
ROE
-26.9%
Marża Zysku Netto
-76.6%
O Zymeworks Inc. - Common Stock Przegląd firmy z Wikipedii
Zymeworks Inc. is a publicly held biotechnology company based in Vancouver, British Columbia, that develops protein therapeutics for the treatment of cancer as well as for autoimmune and inflammatory diseases. The products are based upon the company's molecular modeling software for optimizing protein structure. In 2014, Zymeworks raised $44 million across various funding rounds according to PitchBook, placing it among the top 10 HealthTech businesses in the world to raise the most capital that year. In May 2017, Zymeworks held an IPO on the Toronto Stock Exchange, raising $59 million. This was the largest Canadian biotech IPO in more than a decade. By alphabetical order, Zymeworks is the last company on the Toronto Stock Exchange.
Czytaj więcej
Zymeworks Inc. is a publicly held biotechnology company based in Vancouver,
British Columbia, that develops protein therapeutics for the treatment of cancer as well as for autoimmune and inflammatory diseases. The products are based upon the company's molecular modeling software for optimizing protein structure. In 2014, Zymeworks raised $44 million across various funding rounds according to PitchBook, placing it among the top 10 HealthTech businesses in the world to raise the most capital that year. In May 2017, Zymeworks held an IPO on the Toronto Stock Exchange, raising $59 million. This was the largest Canadian biotech IPO in more than a decade. By alphabetical order, Zymeworks is the last company on the Toronto Stock Exchange.
In May 2019, Zymeworks announced that GSK has expanded its 2016 licensing and collaboration agreement for the research, development and commercialization of bispecific antibodies across multiple disease areas. The extended agreement has meant that GSK can have access to Zymeworks' heavy-light chain pairing technology, which enables the development of bispecific and multifunctional therapeutics.
In September 2019, Zymeworks announced that, following their clinical trials, it has been confirmed that their ZW25 monotherapy can provide durable disease control in patients with a variety of HER2-expressing solid tumors that have progressed following standard of care treatments.
In May 2022, Zymeworks rejected an unsolicited takeover proposal from a Dubai hedge fund, All Blue Falcons FZE, an arm of All Blue Capital.
Azymetric
This is an IgG1-based heterodimeric antibody scaffold that consists of two different heavy chains engineered to exclusively assemble into a single molecule, allowing bi-specific binding to two different antigens or drug targets. The Azymetric scaffold is engineered by making amino acid changes in the CH3 region of the constant Fc domain of the IgG1. This scaffold can also be engineered with tailored effector function and optimized serum half-life.
Awards and recognition
Deal of the Year, Lifesciences BC Awards, 2018
Life Sciences Company of the Year, Lifesciences BC Awards, 2016
Emerging company of the year – Health, BIOTECanada Gold Leaf Awards, 2015
12th Place, BC's Leading Innovators, 2011
Life Science Emerging Rocket, 2009, 2010, 2011
Early stage Company of the year – Industrial & Agriculture, BIOTECanada Gold Leaf Awards, 2009
== References ==
Źródło: Wikipedia (Angielski), CC BY-SA 4.0 · Zobacz w Wikipedii ↗
ZYME Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$29.59
Kapitalizacja Rynkowa
$2.21B
P/E (TTM)
-27.4
EPS (TTM)
$-1.08
Przychody (TTM)
$106M
Stopa dywidendy
—
ROE
-26.9%
D/E Dług/Kapitał
—
Zakres 52 tyg.
$14 – $30
ZYME Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Configure
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody i Zysk Netto
$106M
2020-12-31
→
2025-12-31
EPS
$-1.08
2020-12-31
→
2025-12-31
Wolny przepływ pieniężny
$-35M
2023-12-31
→
2025-12-31
Marże
-76.6%
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Wskaźnik
Trend 5-letni
ZYME
Mediana porównawcza
P/E (TTM)
-27.4
—
P/S (TTM)
20.8
418.4
P/B
8.2
2.3
Price / FCF (Cena / FCF)
-64.0
—
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Wskaźnik
Trend 5-letni
ZYME
Mediana porównawcza
Operating Margin (Marża Operacyjna)
-87.3%
—
Net Profit Margin (Marża Zysku Netto)
-76.6%
-549.8%
ROA
-20.0%
-41.8%
ROE
-26.9%
-54.1%
ROIC
-35.1%
—
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Wskaźnik
Trend 5-letni
ZYME
Mediana porównawcza
Current Ratio (Wskaźnik bieżący)
5.9
12.6
Quick Ratio (Wskaźnik Szybkości)
1.1
—
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Wskaźnik
Trend 5-letni
ZYME
Mediana porównawcza
Revenue YoY (Przychody R/R)
38.9%
—
Revenue CAGR 3Y (Przychody CAGR 3L)
-36.4%
—
Revenue CAGR 5Y (Przychody CAGR 5L)
22.2%
—
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Wskaźnik
Trend 5-letni
ZYME
Mediana porównawcza
ZYME Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
KUP
18 analityków
- Mocne kupno 6 33,3%
- Kup 11 61,1%
- Trzymaj 1 5,6%
- Sprzedaj 0 0,0%
- Mocna sprzedaż 0 0,0%
12-miesięczny cel cenowy
12 analityków · 2026-08-23
Mediana
$38.50
← Poniżej wszystkich celów
$29.59
Niski
$31.00
Wysoki
$58.00
Średni cel
$38.50
+30,1%
Średnia cel
$40.33
+36,3%
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
0.01%
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 30 czerwca 2026 | $-0.62 | $-0.50 | -0.12% |
| 31 marca 2026 | $-0.59 | $-0.20 | -0.39% |
| 31 grudnia 2025 | $-0.55 | $-0.42 | -0.13% |
| 30 września 2025 | $-0.26 | $-0.33 | 0.07% |
| 30 czerwca 2025 | $0.03 | $-0.50 | 0.53% |
| 31 marca 2025 | $-0.30 | $-0.42 | 0.12% |
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| ZYME | $1.97B | -24.4 | 38.9% | -76.6% | -26.9% | — |
| AUPH | $2.11B | 7.7 | 20.4% | 101.5% | 62.7% | — |
| ABUS | $926M | -28.3 | 128.2% | -237.9% | -42.0% | — |
| ACOG | $141M | -5.5 | — | -202.2% | -43.8% | — |
| PMN | $15M | -0.3 | — | — | 4840.3% | — |
| XENE | $3.59B | -10.3 | — | -4612.1% | -56.9% | — |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 14
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue | $106M | $76M | $76M | $412M | $27M | |
| R&D Expense | · | · | $144M | $209M | $200M | |
| SG&A Expense | $62M | $62M | $70M | $73M | $43M | |
| Operating Expenses | $199M | $213M | $214M | $282M | $242M | |
| Operating Income | $-93M | $-137M | $-138M | $131M | $-216M | |
| Other Non-op | $51.0K | $-218.0K | $291.0K | $-42.0K | $118.0K | |
| Pretax Income | $-80M | $-117M | $-119M | $135M | $-212M | |
| Income Tax | $1M | $6M | $-568.0K | $11M | $-516.0K | |
| Net Income | $-81M | $-123M | $-119M | $124M | $-212M | |
| EPS (Basic) | $-1.08 | $-1.62 | $-1.72 | $1.91 | $-4.11 | |
| EPS (Diluted) | $-1.08 | $-1.62 | $-1.72 | $1.90 | $-4.61 | |
| Shares (Basic) | 75,404,897 | 75,846,681 | 68,863,010 | 65,194,775 | 51,553,869 | |
| Shares (Diluted) | 75,413,396 | 75,878,738 | 68,863,010 | 65,249,184 | 52,131,596 | |
| EBITDA | $-93M | $-137M | $-138M | · | · |
Bilans 23
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $41M | $66M | $158M | $401M | $202M | |
| Short-term Investments | · | · | $217M | $91M | $51M | |
| Receivables | $5M | $56M | $19M | $33M | $16M | |
| Prepaid Expense | $15M | $19M | $19M | $19M | $20M | |
| Current Assets | $249M | $300M | $413M | $545M | $288M | |
| PP&E (Net) | $16M | $18M | $20M | $25M | $23M | |
| PP&E (Gross) | $36M | $35M | $41M | $38M | $37M | |
| Accum. Depreciation | $21M | $18M | $21M | $13M | $14M | |
| Goodwill | $12M | $12M | $12M | $12M | $12M | |
| Intangibles | $1M | $5M | $8M | $9M | $4M | |
| Total Assets | $347M | $463M | $581M | $649M | $389M | |
| Accounts Payable | $36M | $60M | $46M | $87M | $63M | |
| Current Liabilities | $42M | $88M | $56M | $96M | $72M | |
| Capital Leases | $15M | $16M | $22M | $25M | $31M | |
| Deferred Tax | $6M | $5M | $3M | $2M | $2M | |
| Other Non-current Liabilities | $278.0K | $923.0K | $2M | $3M | $3M | |
| Total Liabilities | $78M | $124M | $116M | $156M | $140M | |
| Common Stock | $1.11B | $1.02B | $997M | $886M | $741M | |
| Retained Earnings | $-953M | $-830M | $-677M | $-559M | $-683M | |
| AOCI | $-6M | $-7M | $-7M | $-7M | $-7M | |
| Stockholders' Equity | $269M | $339M | $465M | $493M | $249M | |
| Liabilities + Equity | $347M | $463M | $581M | $649M | $389M | |
| Shares Outstanding | 74,638,413 | 68,964,319 | 70,115,997 | 63,059,501 | 46,633,935 |
Przepływy pieniężne 14
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Stock-based Comp | $28M | $18M | $8M | $4M | $11M | |
| Deferred Tax | $945.0K | $691.0K | $-757.0K | $2M | $-953.0K | |
| Amort. of Intangibles | $4M | $4M | $3M | $1M | $3M | |
| Restructuring | · | · | $0 | · | · | |
| Operating Cash Flow | $-33M | $-110M | $-118M | $144M | $-192M | |
| CapEx | $2M | $2M | $2M | $8M | $12M | |
| Investing Cash Flow | $27M | $39M | $-207M | $-54M | $145M | |
| Stock Issued | $0 | $0 | $26M | $108M | $0 | |
| Stock Repurchased | $42M | $30M | $0 | $0 | · | |
| Net Stock Activity | $-42M | $-30M | $26M | · | · | |
| Financing Cash Flow | $-19M | $-20M | $82M | $109M | $8M | |
| Net Change in Cash | $-25M | $-91M | $-243M | $199M | $-40M | |
| Taxes Paid | $1M | $3M | $165.0K | $10M | · | |
| Free Cash Flow | $-35M | $-112M | $-121M | · | · |
Rentowność 7
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Operating Margin | -87.3% | -179.7% | -181.6% | · | · | |
| Net Margin | -76.6% | -160.8% | -156.1% | · | · | |
| Pretax Margin | -75.3% | -152.8% | -156.9% | · | · | |
| EBITDA Margin | -87.3% | -179.7% | -181.6% | · | · | |
| ROA | -20.0% | -23.5% | -19.3% | · | · | |
| ROE | -26.9% | -34.8% | -26.7% | · | · | |
| ROIC | -35.1% | -42.6% | -29.6% | · | · |
Płynność i wypłacalność 2
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Current Ratio | 5.9 | 3.4 | 7.4 | · | · | |
| Quick Ratio | 1.1 | 1.4 | 7.1 | · | · |
Efektywność 2
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.1 | 0.1 | · | · | |
| Receivables Turnover | 3.5 | 2.0 | 2.9 | · | · |
Stopy Wzrostu 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue YoY | 38.9% | 0.38% | -81.6% | 1446.0% | -31.5% | |
| Revenue CAGR 3Y | -36.4% | 41.9% | 25.0% | · | · | |
| Revenue CAGR 5Y | 22.2% | · | · | · | · |
Wycena (TTM) 10
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue TTM | $106M | $76M | $76M | $412M | · | |
| Net Income TTM | $-81M | $-123M | $-119M | $124M | · | |
| Market Cap | $1.97B | $1.01B | $729M | · | · | |
| P/E | -24.4 | -9.0 | -6.0 | 4.1 | · | |
| P/S | 18.5 | 13.2 | 9.6 | · | · | |
| P/B | 7.3 | 3.0 | 1.6 | · | · | |
| P / Tangible Book | 7.7 | 3.1 | 1.6 | 1.0 | · | |
| P / Cash Flow | -59.5 | -9.2 | -6.2 | · | · | |
| P / FCF | -56.9 | -9.0 | -6.0 | · | · | |
| Earnings Yield | -4.1% | -11.1% | -16.6% | 24.2% | · |
Rachunek zysków i strat 14
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5M | $2M | $3M | $28M | $49M | $27M | $31M | $16M | $19M | $10M | $17M | $17M | $7M | $36M | $402M | $3M | |
| R&D Expense | · | · | · | · | · | · | · | · | · | $32M | · | $33M | $39M | $46M | · | $37M | |
| SG&A Expense | $19M | $15M | $15M | $14M | $15M | $17M | $16M | $14M | $16M | $16M | $15M | $17M | $22M | $17M | $30M | $16M | |
| Operating Expenses | $47M | $50M | $47M | $50M | $49M | $53M | $53M | $50M | $62M | $48M | $40M | $50M | $61M | $63M | $83M | $53M | |
| Operating Income | $-42M | $-47M | $-44M | $-22M | $-674.0K | $-26M | $-22M | $-34M | $-43M | $-38M | $-23M | $-33M | $-54M | $-27M | $319M | $-50M | |
| Other Non-op | $196.0K | $120.0K | $-18.0K | $26.0K | $-621.0K | $49.0K | $-253.0K | $-37.0K | $53.0K | $19.0K | $-278.0K | $370.0K | $230.0K | $-31.0K | $-27.0K | $-98.0K | |
| Pretax Income | $-45M | $-46M | $-41M | $-18M | $2M | $-22M | $-18M | $-30M | $-38M | $-32M | $-19M | $-28M | $-49M | $-23M | $320M | $-48M | |
| Income Tax | $-273.0K | $-2M | $-270.0K | $1M | $-186.0K | $496.0K | $6M | $226.0K | $68.0K | $75.0K | $-5M | $1M | $2M | $1M | $11M | $-29.0K | |
| Net Income | $-45M | $-44M | $-41M | $-20M | $2M | $-23M | $-24M | $-30M | $-38M | $-32M | $-14M | $-29M | $-51M | $-24M | $309M | $-48M | |
| EPS (Basic) | $-0.62 | $-0.59 | $-0.55 | $-0.26 | $0.03 | $-0.30 | $-0.32 | $-0.39 | $-0.49 | $-0.42 | $-0.19 | $-0.41 | $-0.76 | $-0.36 | $4.78 | $-0.72 | |
| EPS (Diluted) | $-0.62 | $-0.59 | $-0.55 | $-0.26 | $0.03 | $-0.30 | $-0.32 | $-0.39 | $-0.49 | $-0.42 | $-0.18 | $-0.41 | $-0.76 | $-0.37 | $4.78 | $-0.72 | |
| Shares (Basic) | 72,993,313 | 74,668,790 | -150,871,069 | 75,767,778 | 75,337,168 | 75,171,020 | -152,889,276 | 76,128,531 | 76,392,593 | 76,214,833 | -135,733,099 | 70,575,773 | 67,281,028 | 66,739,308 | -129,002,888 | 66,477,016 | |
| Shares (Diluted) | 72,993,313 | 74,694,762 | -152,966,654 | 75,775,214 | 77,378,449 | 75,226,387 | -152,922,738 | 76,157,101 | 76,396,217 | 76,248,158 | -135,739,304 | 70,575,773 | 67,284,511 | 66,742,030 | -128,961,927 | 66,478,157 | |
| EBITDA | $-42M | $-47M | · | $-22M | $-674.0K | $-26M | · | $-34M | $-43M | $-38M | · | $-33M | $-54M | $-27M | · | $-50M |
Bilans 23
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $179M | $244M | $41M | $65M | $98M | $76M | $66M | $122M | $71M | $115M | · | $94M | $142M | $182M | · | $96M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | · | $201M | $198M | $159M | · | $70M | |
| Receivables | $6M | $5M | $5M | $29M | $3M | $25M | $56M | $24M | $32M | $31M | · | $67M | $49M | $67M | · | $7M | |
| Prepaid Expense | $22M | $16M | $15M | $10M | $12M | $17M | $19M | $23M | $21M | $18M | · | $12M | $31M | $19M | · | $18M | |
| Current Assets | $298M | $386M | $249M | $292M | $296M | $306M | $300M | $344M | $383M | $394M | · | $375M | $420M | $426M | · | $191M | |
| PP&E (Net) | $14M | $15M | $16M | $16M | $16M | $17M | $18M | $18M | $18M | $19M | · | $21M | $22M | $24M | · | $26M | |
| PP&E (Gross) | · | · | $36M | · | · | · | $35M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $21M | · | · | · | $18M | · | · | · | · | · | · | · | · | · | |
| Goodwill | $12M | $12M | $12M | $12M | $12M | $12M | $12M | $12M | $12M | $12M | · | $12M | $12M | $12M | · | $12M | |
| Intangibles | $998.0K | $1M | $1M | $1M | $2M | $3M | $5M | $6M | $7M | $7M | · | $8M | $7M | $8M | · | $9M | |
| Total Assets | $397M | $478M | $347M | $397M | $408M | $426M | $463M | $487M | $516M | $554M | · | $556M | $602M | $601M | · | $300M | |
| Accounts Payable | $27M | $30M | $36M | $34M | $31M | $38M | $60M | $52M | $44M | $47M | · | $68M | $70M | $59M | · | $52M | |
| Current Liabilities | $47M | $36M | $42M | $42M | $39M | $65M | $88M | $84M | $55M | $57M | · | $73M | $94M | $67M | · | $58M | |
| Capital Leases | $13M | $14M | $15M | $16M | $15M | $15M | $16M | $17M | $17M | $21M | · | $22M | $23M | $24M | · | $25M | |
| Deferred Tax | $4M | $4M | $6M | $5M | $5M | $5M | $5M | $3M | $3M | $3M | · | $2M | $2M | $2M | · | $2M | |
| Other Non-current Liabilities | $278.0K | $278.0K | $278.0K | $278.0K | $828.0K | $856.0K | $923.0K | $929.0K | $1M | $2M | · | $2M | $4M | $4M | · | $3M | |
| Total Liabilities | $317M | $315M | $78M | $77M | $74M | $101M | $124M | $120M | $109M | $116M | · | $132M | $153M | $127M | · | $121M | |
| Common Stock | $1.13B | $1.13B | $1.11B | $1.09B | $1.07B | $1.02B | $1.02B | $1.01B | $1.01B | $1.00B | · | $932M | $929M | $900M | · | $885M | |
| Retained Earnings | $-1.17B | $-1.07B | $-953M | $-886M | $-851M | $-853M | $-830M | $-798M | $-747M | $-709M | · | $-663M | $-634M | $-583M | · | $-868M | |
| AOCI | $-7M | $-7M | $-6M | $-6M | $-6M | $-6M | $-7M | $-6M | $-8M | $-8M | · | $-8M | $-8M | $-6M | · | $-7M | |
| Stockholders' Equity | $80M | $164M | $269M | $320M | $335M | $325M | $339M | $367M | $406M | $438M | $465M | $424M | $449M | $474M | $493M | $180M | |
| Liabilities + Equity | $397M | $478M | $347M | $397M | $408M | $426M | $463M | $487M | $516M | $554M | · | $556M | $602M | $601M | · | $300M | |
| Shares Outstanding | 71,412,072 | 73,102,689 | 74,638,413 | 75,139,281 | 74,846,147 | 69,584,811 | 68,964,319 | 69,584,882 | 70,831,545 | 70,677,106 | · | 67,922,559 | 67,687,384 | 64,083,770 | · | 61,694,387 |
Przepływy pieniężne 12
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $11M | $7M | $9M | $7M | $6M | $6M | $5M | $5M | $5M | $4M | $3M | $2M | $367.0K | $2M | $4M | $5M | |
| Amort. of Intangibles | $176.0K | $176.0K | $185.0K | $648.0K | $2M | $2M | $2M | $980.0K | $812.0K | $702.0K | $673.0K | $672.0K | $678.0K | $679.0K | $529.0K | $166.0K | |
| Operating Cash Flow | $-32M | $-46M | $-10M | $-31M | $12M | $-3M | $-42M | $-6M | $-25M | $-38M | $14M | $-43M | $-6M | $-83M | $327M | $-73M | |
| CapEx | $0 | $216.0K | $581.0K | $410.0K | $514.0K | $16.0K | $314.0K | $899.0K | $593.0K | $185.0K | $356.0K | $930.0K | $802.0K | $386.0K | $348.0K | $981.0K | |
| Investing Cash Flow | $17M | $70M | $5M | $368.0K | $9M | $12M | $-6M | $72M | $-20M | $-7M | $-1M | $-7M | $-61M | $-138M | $-22M | $-30M | |
| Stock Issued | · | · | · | · | · | · | $0 | $0 | · | · | $0 | $0 | $26M | $0 | $0 | $0 | |
| Stock Repurchased | $52M | $76M | $25M | $16M | $0 | $0 | $9M | · | · | · | $0 | · | · | · | · | · | |
| Net Stock Activity | · | $-76M | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | |
| Financing Cash Flow | $-50M | $179M | $-19M | $-2M | $1M | $1M | $-9M | $-15M | $1M | $2M | $51M | $2M | $28M | $2M | $-377.0K | $628.0K | |
| Net Change in Cash | $-65M | $203M | $-24M | $-33M | $22M | $10M | $-56M | $51M | $-44M | $-43M | $63M | $-48M | $-39M | $-219M | $305M | $-103M | |
| Taxes Paid | $863.0K | $245.0K | $107.0K | $660.0K | $196.0K | $387.0K | $3M | $106.0K | $106.0K | $0 | · | · | · | · | · | · | |
| Free Cash Flow | · | $-46M | · | · | · | $-3M | · | · | · | $-38M | · | · | · | $-84M | · | · |
Rentowność 7
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -919.0% | -1956.7% | · | -80.1% | -1.4% | -94.5% | · | -213.8% | -222.9% | -376.9% | · | -201.4% | -772.8% | -76.7% | · | -1914.0% | |
| Net Margin | -980.8% | -1834.0% | · | -71.0% | 4.8% | -83.5% | · | -186.6% | -195.8% | -315.6% | · | -173.8% | -730.5% | -68.5% | · | -1818.6% | |
| Pretax Margin | -986.8% | -1925.0% | · | -66.1% | 4.4% | -81.7% | · | -185.2% | -195.5% | -314.8% | · | -167.1% | -706.9% | -64.5% | · | -1819.7% | |
| EBITDA Margin | -919.0% | -1956.7% | · | -80.1% | -1.4% | -94.5% | · | -213.8% | -222.9% | -376.9% | · | -201.4% | -772.8% | -76.7% | · | -1914.0% | |
| ROA | -11.2% | -9.8% | · | -4.4% | 0.50% | -4.6% | · | -5.7% | -6.7% | -5.5% | · | -6.7% | -17.0% | -8.1% | · | -31.9% | |
| ROE | -21.7% | -18.1% | · | -5.7% | 0.63% | -5.9% | · | -7.5% | -8.8% | -6.9% | · | -9.5% | -22.8% | -10.3% | · | -53.2% | |
| ROIC | -52.2% | -27.4% | · | -7.4% | -0.22% | -8.1% | · | -9.4% | -10.6% | -8.6% | · | -8.2% | -12.5% | -6.1% | · | -28.0% |
Płynność i wypłacalność 2
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.3 | 10.8 | · | 6.9 | 7.7 | 4.7 | · | 4.1 | 7.0 | 6.9 | · | 5.1 | 4.5 | 6.3 | · | 3.3 | |
| Quick Ratio | 3.9 | 7.0 | · | 2.2 | 2.6 | 1.5 | · | 1.7 | 1.9 | 2.6 | · | 5.0 | 4.2 | 6.1 | · | 3.0 |
Efektywność 2
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.1 | 0.1 | 0.1 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.1 | · | 0.0 | |
| Receivables Turnover | 1.1 | 0.2 | · | 1.0 | 2.8 | 1.0 | · | 0.4 | 0.5 | 0.2 | · | 0.4 | 0.3 | 1.1 | · | 0.8 |
Wycena (TTM) 10
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $83M | $106M | · | $119M | $111M | $72M | · | $62M | $53M | $69M | · | $62M | $51M | $46M | · | $14M | |
| Net Income TTM | $-106M | $-84M | · | $-70M | $-88M | $-122M | · | $-128M | $-149M | $-136M | · | $-152M | $-188M | $-209M | · | $-246M | |
| Market Cap | $1.87B | $1.83B | · | $1.28B | $939M | $829M | · | $873M | $603M | $744M | · | $431M | $585M | $579M | · | $379M | |
| P/E | -18.2 | -22.4 | · | -18.6 | -10.9 | -7.4 | · | -7.3 | -4.1 | -5.4 | · | -2.8 | -3.1 | -2.8 | · | -1.5 | |
| P/S | 22.4 | 17.3 | · | 10.7 | 8.5 | 11.4 | · | 14.1 | 11.4 | 10.8 | · | 7.0 | 11.5 | 12.7 | · | 26.4 | |
| P/B | 23.2 | 11.2 | · | 4.0 | 2.8 | 2.6 | · | 2.4 | 1.5 | 1.7 | · | 1.0 | 1.3 | 1.2 | · | 2.1 | |
| P / Tangible Book | 27.7 | 12.2 | · | 4.2 | 2.9 | 2.7 | · | 2.5 | 1.6 | 1.8 | · | 1.1 | 1.4 | 1.3 | · | 2.4 | |
| P / Cash Flow | · | -40.0 | · | · | · | -243.3 | · | · | · | -19.7 | · | · | · | -7.0 | · | · | |
| P / FCF | · | -39.9 | · | · | · | -242.1 | · | · | · | -19.6 | · | · | · | -6.9 | · | · | |
| Earnings Yield | -5.5% | -4.5% | · | -5.4% | -9.2% | -13.4% | · | -13.6% | -24.4% | -18.6% | · | -35.6% | -32.6% | -35.9% | · | -67.2% |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Przychody | $106M | $76M | $76M | $412M | $27M |
| Marża Operacyjna % | -87.3% | -179.7% | -181.6% | — | — |
| Zysk netto | $-81M | $-123M | $-119M | $124M | $-212M |
| Rozwodniony EPS | $-1.08 | $-1.62 | $-1.72 | $1.90 | $-4.61 |
Bilans
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wskaźnik bieżący | 5.9 | 3.4 | 7.4 | — | — |
| Wskaźnik Szybkości | 1.1 | 1.4 | 7.1 | — | — |
Przepływy pieniężne
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $-35M | $-112M | $-121M | — | — |
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
📊
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Właściciele instytucjonalni (13F) 217 emitentów · $1.5B łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 23 (-18 vs poprzedni kw.) | 30 (-1 vs poprzedni kw.) | 57 (-16 vs poprzedni kw.) | 70 (+11 vs poprzedni kw.) | +196K |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| EcoR1 Capital, LLC | $600 445 942 | 22 970 388 | 39,27% | Akcje |
| Rubric Capital Management LP | $182 980 000 | 7 000 000 | 11,97% | Akcje |
| PERCEPTIVE ADVISORS LLC | $109 342 391 | 4 182 953 | 7,15% | Akcje |
| BVF INC/IL | $95 388 572 | 3 649 142 | 6,24% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $40 752 208 | 1 558 998 | 2,67% | Akcje |
| Assenagon Asset Management S.A. | $32 727 986 | 1 252 027 | 2,14% | Akcje |
| Nextech Invest Ltd. | $29 118 548 | 1 113 946 | 1,90% | Akcje |
| STATE STREET CORP | $28 445 966 | 1 088 216 | 1,86% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $24 486 776 | 936 755 | 1,60% | Akcje |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $23 259 000 | 889 802 | 1,52% | Akcje |
| CITADEL ADVISORS LLC | $21 330 894 | 816 025 | 1,40% | Akcje |
| FMR LLC | $18 355 822 | 702 212 | 1,20% | Akcje |
| Prosight Management, LP | $17 629 705 | 674 434 | 1,15% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $16 322 460 | 624 447 | 1,07% | Akcje |
| Nextech Invest Ltd. | $16 308 169 | 1 113 946 | 1,07% | Akcje |
| Qube Research & Technologies Ltd | $15 516 443 | 593 590 | 1,01% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $13 332 236 | 510 032 | 0,87% | Akcje |
| Redmile Group, LLC | $12 851 836 | 491 654 | 0,84% | Akcje |
| Capricorn Fund Managers Ltd | $12 717 868 | 486 529 | 0,83% | Akcje |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $10 939 512 | 418 497 | 0,72% | Akcje |
| Hillsdale Investment Management Inc. | $10 009 581 | 382 922 | 0,65% | Akcje |
| GOLDMAN SACHS GROUP INC | $9 345 338 | 357 511 | 0,61% | Akcje |
| FIRST TRUST ADVISORS LP | $8 897 088 | 340 363 | 0,58% | Akcje |
| Granahan Investment Management, LLC | $8 787 144 | 336 157 | 0,57% | Akcje |
| Pictet Asset Management Holding SA | $7 446 189 | 308 187 | 0,49% | Akcje |
| PICTON MAHONEY ASSET MANAGEMENT | $7 092 908 | 271 343 | 0,46% | Akcje |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $5 849 243 | 223 766 | 0,38% | Akcje |
| SummitTX Capital, L.P. | $5 510 364 | 210 802 | 0,36% | Akcje |
| Man Group plc | $5 509 763 | 210 779 | 0,36% | Akcje |
| BANK OF AMERICA CORP /DE/ | $5 182 437 | 198 257 | 0,34% | Akcje |
| STATE OF WISCONSIN INVESTMENT BOARD | $4 066 835 | 155 579 | 0,27% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $3 984 154 | 152 416 | 0,26% | Akcje |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $3 960 132 | 151 497 | 0,26% | Akcje |
| KENNEDY CAPITAL MANAGEMENT LLC | $3 800 390 | 145 386 | 0,25% | Akcje |
| D. E. Shaw & Co., Inc. | $3 785 255 | 144 807 | 0,25% | Akcje |
| DIADEMA PARTNERS LP | $3 715 330 | 142 132 | 0,24% | Akcje |
| BlackRock, Inc. | $3 614 744 | 138 284 | 0,24% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $3 408 656 | 130 400 | 0,22% | Opcja kupna |
| CITIGROUP INC | $3 364 872 | 128 725 | 0,22% | Akcje |
| XTX Topco Ltd | $3 290 425 | 125 877 | 0,22% | Akcje |
| PANAGORA ASSET MANAGEMENT INC | $3 100 282 | 118 603 | 0,20% | Akcje |
| PLATINUM INVESTMENT MANAGEMENT LTD | $2 749 510 | 105 184 | 0,18% | Akcje |
| AXA Investment Managers S.A. | $2 705 745 | 158 416 | 0,18% | Akcje |
| Manatuck Hill Partners, LLC | $2 614 000 | 100 000 | 0,17% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2 451 932 | 93 800 | 0,16% | Opcja sprzedaży |
| KORNITZER CAPITAL MANAGEMENT INC /KS | $2 321 232 | 88 800 | 0,15% | Akcje |
| MACKENZIE FINANCIAL CORP | $2 293 654 | 87 745 | 0,15% | Akcje |
| VANGUARD GROUP INC | $2 251 979 | 85 529 | 0,15% | Akcje |
| Y-Intercept (Hong Kong) Ltd | $2 181 514 | 83 455 | 0,14% | Akcje |
| LMR Partners LLP | $2 156 550 | 82 500 | 0,14% | Akcje |
| PRINCIPAL FINANCIAL GROUP INC | $2 127 587 | 81 392 | 0,14% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $2 094 337 | 80 120 | 0,14% | Akcje |
| TEMA ETFS LLC | $2 000 422 | 75 975 | 0,13% | Akcje |
| RHUMBLINE ADVISERS | $1 962 211 | 75 066 | 0,13% | Akcje |
| Swiss National Bank | $1 939 588 | 74 200 | 0,13% | Akcje |
| MARTINGALE ASSET MANAGEMENT L P | $1 915 592 | 73 282 | 0,13% | Akcje |
| TWO SIGMA INVESTMENTS, LP | $1 878 786 | 71 874 | 0,12% | Akcje |
| Dana Investment Advisors, Inc. | $1 873 192 | 71 660 | 0,12% | Akcje |
| CREDIT AGRICOLE S A | $1 855 940 | 71 000 | 0,12% | Akcje |
| Fisher Asset Management, LLC | $1 850 057 | 70 775 | 0,12% | Akcje |
| SEGALL BRYANT & HAMILL, LLC | $1 747 093 | 66 836 | 0,11% | Akcje |
| Verdad Advisers, LP | $1 743 224 | 66 688 | 0,11% | Akcje |
| Susquehanna Portfolio Strategies, LLC | $1 705 583 | 65 248 | 0,11% | Akcje |
| Campbell & CO Investment Adviser LLC | $1 591 246 | 60 874 | 0,10% | Akcje |
| ALLIANCEBERNSTEIN L.P. | $1 399 636 | 55 896 | 0,09% | Akcje |
| CITADEL ADVISORS LLC | $1 364 508 | 52 200 | 0,09% | Opcja kupna |
| Virtus Investment Advisers, LLC | $1 328 566 | 50 825 | 0,09% | Akcje |
| ENVESTNET ASSET MANAGEMENT INC | $1 272 365 | 48 675 | 0,08% | Akcje |
| Quantinno Capital Management LP | $1 245 362 | 47 642 | 0,08% | Akcje |
| WELLS FARGO & COMPANY/MN | $1 122 164 | 42 929 | 0,07% | Akcje |
| VICTORY CAPITAL MANAGEMENT INC | $1 111 577 | 42 524 | 0,07% | Akcje |
| Bank of New York Mellon Corp | $1 076 785 | 41 193 | 0,07% | Akcje |
| MARSHALL WACE, LLP | $1 070 380 | 40 948 | 0,07% | Akcje |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | $1 033 419 | 39 534 | 0,07% | Akcje |
| Aquilo Capital Management, LLC | $1 006 181 | 84 482 | 0,07% | Akcje |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $965 141 | 36 922 | 0,06% | Akcje |
| TUDOR INVESTMENT CORP ET AL | $953 352 | 36 471 | 0,06% | Akcje |
| HighTower Advisors, LLC | $943 654 | 36 100 | 0,06% | Akcje |
| Persistent Asset Partners Ltd | $939 341 | 35 935 | 0,06% | Akcje |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $936 221 | 37 389 | 0,06% | Akcje |
| WELLINGTON MANAGEMENT GROUP LLP | $904 653 | 34 608 | 0,06% | Akcje |
| HighVista Strategies LLC | $889 100 | 34 013 | 0,06% | Akcje |
| COMMONWEALTH EQUITY SERVICES, LLC | $837 838 | 32 052 | 0,05% | Akcje |
| TWO SIGMA ADVISERS, LP | $827 157 | 31 415 | 0,05% | Akcje |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $807 360 | 30 886 | 0,05% | Akcje |
| SBI Okasan Asset Management Co.Ltd. | $771 200 | 32 000 | 0,05% | Akcje |
| VIRGINIA RETIREMENT SYSTEMS ET Al | $735 529 | 27 935 | 0,05% | Akcje |
| MetLife Investment Management, LLC | $728 888 | 27 884 | 0,05% | Akcje |
| JOURNEY STRATEGIC WEALTH LLC | $722 304 | 28 846 | 0,05% | Akcje |
| STRS OHIO | $692 710 | 26 500 | 0,05% | Akcje |
| VANGUARD ASSET MANAGEMENT, Ltd | $686 933 | 26 279 | 0,04% | Akcje |
| Brevan Howard Capital Management LP | $678 490 | 25 956 | 0,04% | Akcje |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $657 735 | 25 162 | 0,04% | Akcje |
| RITHOLTZ WEALTH MANAGEMENT | $633 712 | 24 243 | 0,04% | Akcje |
| BNP PARIBAS FINANCIAL MARKETS | $607 206 | 23 229 | 0,04% | Akcje |
| Duncan Williams Asset Management, LLC | $577 563 | 22 095 | 0,04% | Akcje |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $564 049 | 21 578 | 0,04% | Akcje |
| BARCLAYS PLC | $524 577 | 20 068 | 0,03% | Akcje |
| SIMPLEX TRADING, LLC | $507 926 | 19 431 | 0,03% | Akcje |
| Invesco Ltd. | $491 720 | 18 811 | 0,03% | Akcje |
Insiderzy spółki 28 insiderów · 12 dyrektorzy generalni · 17 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Kenneth Galbraith | Chair & CEO | 12 stycznia 2026 A | 226 842 | 0 | 4 | $-3 337 929 |
| Kristin Stafford | EVP, Chief Financial Officer | 6 kwietnia 2026 A | — | 0 | 0 | $0 |
| Christopher Astle | SVP & Chief Financial Officer | 5 stycznia 2024 A | 6 503 | 0 | 0 | $0 |
| Neil A Klompas | President & COO | 10 marca 2023 M | 17 032 | 0 | 0 | $0 |
| Mark Hollywood | EVP & Chief Operating Officer | 6 lipca 2026 A | 133 852 | 0 | 1 | $-138 740 |
| Paul R Schneider | EVP, General Counsel | 13 maja 2026 A | — | 0 | 0 | $0 |
| Adam Schayowitz | EVP, Head of Research & Development | 9 kwietnia 2026 A | — | 0 | 0 | $0 |
| Scott Platshon | EVP, Chief Business Officer | 9 kwietnia 2026 A | — | 0 | 0 | $0 |
| Paul Andrew Moore | Chief Scientific Officer | 12 stycznia 2026 A | 48 497 | 0 | 3 | $-721 486 |
| Jeffrey T L Smith | EVP & Chief Medical Officer | 12 stycznia 2026 M | 26 708 | 0 | 2 | $-475 562 |
| Leone D Patterson | EVP, Chief Bus & Fin Officer | 6 stycznia 2026 A | 459 | 0 | 0 | $0 |
| Neil Josephson | Chief Medical Officer | 10 listopada 2022 M | 14 449 | 0 | 0 | $0 |
| Gregory A. Ciongoli | Dyrektor | 12 stycznia 2026 A | 488 500 | 0 | 0 | $0 |
| Alessandra Cesano | Dyrektor | 12 stycznia 2026 A | — | 0 | 0 | $0 |
| Carlos Campoy | Dyrektor | 12 stycznia 2026 A | — | 0 | 0 | $0 |
| Robert E Landry | Dyrektor | 12 stycznia 2026 A | — | 0 | 0 | $0 |
| Kelvin Neu | Dyrektor | 12 stycznia 2026 A | — | 0 | 0 | $0 |
| Susan Mahony | Dyrektor | 12 stycznia 2026 A | — | 0 | 0 | $0 |
| Brian N Cherry | Dyrektor | 12 stycznia 2026 A | — | 0 | 0 | $0 |
| EcoR1 Capital, LLC | Dyrektor | 17 stycznia 2025 P | 15 720 161 | 0 | 0 | $0 |
| Nancy Davidson | Dyrektor | 10 grudnia 2024 A | — | 0 | 0 | $0 |
| Neil Gallagher | Dyrektor | 10 grudnia 2024 A | — | 0 | 0 | $0 |
| Derek John Michael Miller | Dyrektor | 10 grudnia 2024 A | — | 0 | 0 | $0 |
| Troy Cox | Dyrektor | 10 grudnia 2024 A | — | 0 | 0 | $0 |
| Kenneth J. Hillan | Dyrektor | 7 grudnia 2023 A | — | 0 | 0 | $0 |
| Hollings Renton | Dyrektor | 7 grudnia 2023 A | — | 0 | 0 | $0 |
| Natalie Sacks | Dyrektor | 21 grudnia 2022 A | — | 0 | 0 | $0 |
| Lota S. Zoth | Dyrektor | 21 grudnia 2022 A | — | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Aktywiści i właściciele 5%+ 2 akcje
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| EcoR1 Capital, LLC, Oleg Nodelman, EcoR1 Capital Fund Qualified, L.P. ×8 zgłoszenia | 19 listopada 2025 | 30,70% | Aneks | Kampania zarządu | SEC |
| All Blue Falcons FZE, Daniel Edward Llewellen Cookson ×2 zgłoszenia | 28 grudnia 2022 | — | Pierwotne zgłoszenie | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Posiadanie ETF-ów Posiadane przez 43 fundusze ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| CANC · Tema ETF Trust | 1,51% | 105 615 NS | 31 maja 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0,80% | 10 832 NS | 30 kwietnia 2026 | N-PORT |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,49% | 186 247 NS | 30 kwietnia 2026 | N-PORT |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,25% | 110 902 NS | 30 kwietnia 2026 | N-PORT |
| FSCC · Federated Hermes ETF Trust | 0,15% | 16 669 NS | 31 maja 2026 | N-PORT |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,14% | 14 789 SH | 21 sierpnia 2026 | Dziennie |
| IBB · iShares Trust | 0,13% | 526 760 SH | 21 sierpnia 2026 | Dziennie |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,12% | 4 298 SH | 21 sierpnia 2026 | Dziennie |
| VFMO · VANGUARD WELLINGTON FUND | 0,10% | 74 514 SH | 19 sierpnia 2026 | Dziennie |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,10% | 17 393 NS | 30 kwietnia 2026 | N-PORT |
| BIB · ProShares Trust | 0,09% | 2 766 NS | 31 maja 2026 | N-PORT |
| PSC · Principal Exchange-Traded Funds | 0,09% | 80 480 NS | 30 czerwca 2026 | N-PORT |
| IWO · iShares Trust | 0,08% | 434 367 SH | 21 sierpnia 2026 | Dziennie |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,07% | 50 443 SH | 19 sierpnia 2026 | Dziennie |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,06% | 67 654 SH | 21 sierpnia 2026 | Dziennie |
| RSSL · Global X Funds | 0,04% | 21 639 NS | 30 kwietnia 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,04% | 270 692 SH | 19 sierpnia 2026 | Dziennie |
| IWM · iShares Trust | 0,04% | 1 189 250 SH | 21 sierpnia 2026 | Dziennie |
| DFAS · Dimensional ETF Trust | 0,04% | 189 866 NS | 30 kwietnia 2026 | N-PORT |
| RB · ProShares Trust | 0,03% | 15 NS | 31 maja 2026 | N-PORT |
| ITWO · ProShares Trust | 0,03% | 2 345 NS | 31 maja 2026 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0,03% | 10 887 NS | 31 maja 2026 | N-PORT |
| ISCV · iShares Trust | 0,02% | 5 753 SH | 21 sierpnia 2026 | Dziennie |
| UWM · ProShares Trust | 0,02% | 1 834 NS | 31 maja 2026 | N-PORT |
| ISCB · iShares Trust | 0,02% | 1 999 SH | 21 sierpnia 2026 | Dziennie |
| FHLC · FIDELITY COVINGTON TRUST | 0,02% | 16 794 NS | 30 kwietnia 2026 | N-PORT |
| ISCG · iShares Trust | 0,02% | 5 891 SH | 21 sierpnia 2026 | Dziennie |
| URTY · ProShares Trust | 0,01% | 1 855 NS | 31 maja 2026 | N-PORT |
| WSML · iShares Trust | 0,01% | 3 008 SH | 21 sierpnia 2026 | Dziennie |
| VHT · VANGUARD WORLD FUND | 0,01% | 110 298 SH | 19 sierpnia 2026 | Dziennie |
| TILT · FlexShares Trust | 0,01% | 5 236 NS | 30 kwietnia 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,01% | 1 925 NS | 31 maja 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,01% | 26 839 NS | 31 maja 2026 | N-PORT |
| HDG · ProShares Trust | 0,01% | 47 NS | 31 maja 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 5 213 NS | 30 kwietnia 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 72 902 NS | 30 kwietnia 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 12 951 NS | 30 kwietnia 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 14 286 SH | 21 sierpnia 2026 | Dziennie |
| DFUS · Dimensional ETF Trust | 0,00% | 8 364 NS | 30 kwietnia 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,00% | 130 NS | 30 kwietnia 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1 508 613 SH | 19 sierpnia 2026 | Dziennie |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 4 085 SH | 19 sierpnia 2026 | Dziennie |
| SMMV · iShares Trust | — | 16 029 SH | 19 sierpnia 2026 | Dziennie |